These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 144323)

  • 21. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin and the atherosclerotic process.
    Engelberg H
    Pharmacol Rev; 1984 Jun; 36(2):91-110. PubMed ID: 6379681
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of proteinase/antiproteinase inhibitor disequilibrium in the bioincompatibility induced by artificial surfaces.
    Deppisch R; Haug U; Göhl H; Ritz E
    Nephrol Dial Transplant; 1994; 9 Suppl 3():17-23. PubMed ID: 7521027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [THE PHYSIOLOGIC INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. II. SERUM INFUSION INTO THE BLOOD STREAM].
    SCHIMPF K; CIBELIUS A; MARDINI R
    Klin Wochenschr; 1964 Jul; 42():637-40. PubMed ID: 14248608
    [No Abstract]   [Full Text] [Related]  

  • 25. [Heparin].
    Roszkowska W; Worowski K
    Postepy Hig Med Dosw; 1984; 38(1):73-124. PubMed ID: 6387687
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacology of heparin].
    Hoffmann A; Markwardt F
    Z Gesamte Inn Med; 1979 Jan; 34(1):3-8. PubMed ID: 373277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the mechanism of heparin action by modification of its structure.
    Danishefsky I
    Fed Proc; 1977 Jan; 36(1):33-5. PubMed ID: 830555
    [No Abstract]   [Full Text] [Related]  

  • 28. [Heparin-antifibrinolysin complex and its role in the anticoagulation system].
    Kudriashov BA; Pastorova VE; Glotova VL
    Vopr Med Khim; 1967; 13(1):29-33. PubMed ID: 5615047
    [No Abstract]   [Full Text] [Related]  

  • 29. [From heparin to synthetic antithrombotic oligosaccharides].
    Petitou M
    Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The antithrombin effect of heparin; role of heparin concentration].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1952 May; 146(9-10):641-2. PubMed ID: 12998196
    [No Abstract]   [Full Text] [Related]  

  • 31. Heparin-like polysaccharides in intra- and extravascular coagulation reactions.
    Lindahl U; Pejler G
    Acta Med Scand Suppl; 1987; 715():139-44. PubMed ID: 2954435
    [No Abstract]   [Full Text] [Related]  

  • 32. Vascular repair utilising immobilised heparin conjugate for protection against early activation of inflammation and coagulation.
    Nordling S; Hong J; Fromell K; Edin F; Brännström J; Larsson R; Nilsson B; Magnusson PU
    Thromb Haemost; 2015 Jun; 113(6):1312-22. PubMed ID: 25740465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibitors of the serine-proteases of coagulation with special reference to antithrombin III and heparin cofactor II].
    Fontcuberta J
    Sangre (Barc); 1985; 30(4-C):787-91. PubMed ID: 3841417
    [No Abstract]   [Full Text] [Related]  

  • 36. Quality assessment of heparin coatings by their binding capacities of coagulation and complement enzymes.
    Weber N; Wendel HP; Ziemer G
    J Biomater Appl; 2000 Jul; 15(1):8-22. PubMed ID: 10972157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative aspects of antithrombin and heparin in plasma.
    WAUGH DF; FITZGERALD MA
    Am J Physiol; 1956 Mar; 184(3):627-39. PubMed ID: 13302473
    [No Abstract]   [Full Text] [Related]  

  • 38. [Correlation of complement system with coagulation, fibrinolysis, and kinin generation].
    Kondo M
    Rinsho Ketsueki; 1976 Jan; 17(1):1-14. PubMed ID: 135104
    [No Abstract]   [Full Text] [Related]  

  • 39. Hageman-factor-dependent coagulation, fibrinolysis, and kinin generation.
    Austen KF
    Transplant Proc; 1974 Mar; 6(1):39-45. PubMed ID: 4274038
    [No Abstract]   [Full Text] [Related]  

  • 40. Modulations of thrombin activity by polyelectrolytes in the presence of antithrombin III.
    Schiele J; Heuck CC
    Semin Thromb Hemost; 1991; 17 Suppl 1():35-41. PubMed ID: 2068569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.